CF PharmTech Monthly Return: 551,000 H-Share Repurchase Pushes Treasury Stock to 1.22 Million

Bulletin Express06-03

CF PharmTech, Inc. submitted its Monthly Return for the period ended 31 May 2026 to Hong Kong Exchanges and Clearing Limited on 03 June 2026.

• Registered capital remained unchanged at 411.98 million shares with a par value of RMB1.00 per share.

• Issued share structure at month-end: – H shares: 301.01 million in issue (excluding treasury shares) and 1.22 million held in treasury, keeping total H-share issuance at 302.22 million. – Domestic shares: 109.75 million, unchanged. – Aggregate issued shares across both classes stayed at 411.98 million.

• Movements during the month: – 551,000 H shares were repurchased on 16 December 2025 and transferred to treasury in May’s ledger, reducing outstanding H shares by the same amount and increasing treasury shares to 1.22 million. No shares were cancelled.

• Public-float confirmation: the company affirmed compliance with the 24.7 percent minimum public-float requirement for its H shares as of 31 May 2026.

• Capital instruments: there were no outstanding or new share options, warrants, convertibles, or other equity-linked agreements reported for the month.

The filing was signed by Executive Director and Joint Company Secretary Zhu Yuyu, confirming adherence to all relevant listing and regulatory obligations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1149956112?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-03 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1149956112","market":"us","top_or_hot":-1,"title":"CF PharmTech Monthly Return: 551,000 H-Share Repurchase Pushes Treasury Stock to 1.22 Million","media":"Bulletin Express","content":"<p>CF PharmTech, Inc. submitted its Monthly Return for the period ended 31 May 2026 to Hong Kong Exchanges and Clearing Limited on 03 June 2026.</p>\n<p>• Registered capital remained unchanged at 411.98 million shares with a par value of RMB1.00 per share.</p>\n<p>• Issued share structure at month-end:  \n  – H shares: 301.01 million in issue (excluding treasury shares) and 1.22 million held in treasury, keeping total H-share issuance at 302.22 million.  \n  – Domestic shares: 109.75 million, unchanged.  \n  – Aggregate issued shares across both classes stayed at 411.98 million.</p>\n<p>• Movements during the month:  \n  – 551,000 H shares were repurchased on 16 December 2025 and transferred to treasury in May’s ledger, reducing outstanding H shares by the same amount and increasing treasury shares to 1.22 million. No shares were cancelled.</p>\n<p>• Public-float confirmation: the company affirmed compliance with the 24.7 percent minimum public-float requirement for its H shares as of 31 May 2026.</p>\n<p>• Capital instruments: there were no outstanding or new share options, warrants, convertibles, or other equity-linked agreements reported for the month.</p>\n<p>The filing was signed by Executive Director and Joint Company Secretary Zhu Yuyu, confirming adherence to all relevant listing and regulatory obligations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF PharmTech Monthly Return: 551,000 H-Share Repurchase Pushes Treasury Stock to 1.22 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF PharmTech Monthly Return: 551,000 H-Share Repurchase Pushes Treasury Stock to 1.22 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-03 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CF PharmTech, Inc. submitted its Monthly Return for the period ended 31 May 2026 to Hong Kong Exchanges and Clearing Limited on 03 June 2026.</p>\n<p>• Registered capital remained unchanged at 411.98 million shares with a par value of RMB1.00 per share.</p>\n<p>• Issued share structure at month-end:  \n  – H shares: 301.01 million in issue (excluding treasury shares) and 1.22 million held in treasury, keeping total H-share issuance at 302.22 million.  \n  – Domestic shares: 109.75 million, unchanged.  \n  – Aggregate issued shares across both classes stayed at 411.98 million.</p>\n<p>• Movements during the month:  \n  – 551,000 H shares were repurchased on 16 December 2025 and transferred to treasury in May’s ledger, reducing outstanding H shares by the same amount and increasing treasury shares to 1.22 million. No shares were cancelled.</p>\n<p>• Public-float confirmation: the company affirmed compliance with the 24.7 percent minimum public-float requirement for its H shares as of 31 May 2026.</p>\n<p>• Capital instruments: there were no outstanding or new share options, warrants, convertibles, or other equity-linked agreements reported for the month.</p>\n<p>The filing was signed by Executive Director and Joint Company Secretary Zhu Yuyu, confirming adherence to all relevant listing and regulatory obligations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02652","symbol_name":"长风药业","start_time":0,"source_url":"","article_id":"1149956112","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1149956112","pubTimestamp":1780477545,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CF PharmTech, Inc. submitted its Monthly Return for the period ended 31 May 2026 to Hong Kong Exchanges and Clearing Limited on 03 June 2026. • Registered capital remained unchanged at 411.98 million...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02652":"长风药业"},"translate_title":"CF PharmTech月度回报：55.1万股H股回购将库存股推至122万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02652":1},"content_text":"CF PharmTech, Inc. submitted its Monthly Return for the period ended 31 May 2026 to Hong Kong Exchanges and Clearing Limited on 03 June 2026.\n• Registered capital remained unchanged at 411.98 million shares with a par value of RMB1.00 per share.\n• Issued share structure at month-end:  \n  – H shares: 301.01 million in issue (excluding treasury shares) and 1.22 million held in treasury, keeping total H-share issuance at 302.22 million.  \n  – Domestic shares: 109.75 million, unchanged.  \n  – Aggregate issued shares across both classes stayed at 411.98 million.\n• Movements during the month:  \n  – 551,000 H shares were repurchased on 16 December 2025 and transferred to treasury in May’s ledger, reducing outstanding H shares by the same amount and increasing treasury shares to 1.22 million. No shares were cancelled.\n• Public-float confirmation: the company affirmed compliance with the 24.7 percent minimum public-float requirement for its H shares as of 31 May 2026.\n• Capital instruments: there were no outstanding or new share options, warrants, convertibles, or other equity-linked agreements reported for the month.\nThe filing was signed by Executive Director and Joint Company Secretary Zhu Yuyu, confirming adherence to all relevant listing and regulatory obligations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1149956112","isCrawlerRequest":true}